孟山都股票

Keytrud在华第7项适应症拟优先审评：一线结直肠癌

11月12日，默沙东在中国提交的帕博利珠单抗注射液（英文商品名：Keytrud）新适应症上市申请拟纳入优先审评，用于结直肠癌一线治疗。这是帕博利珠单抗在华提交申请上市的第7个适应症。这是帕博利珠单抗在华提交申请上市的第7个适应症。一项代号为KEYNOTE-177的随机、开放标签Ⅲ期临床研究，此研究评估了帕博利珠单抗单药vs标准疗法（化疗贝伐珠单抗或西妥昔单抗）一线治疗高水平微卫星不稳定...

公告 Annual Report for Registered Investment Companies

发表于 2020-03-13 00:00   621次浏览

公告 Certified Shareholder Report

发表于 2020-03-09 22:17   778次浏览

公告 Monthly Portfolio Investments Report on Form N-PORT (Public)

发表于 2020-02-25 22:49   849次浏览

公告 Statement of acquisition of beneficial ownership by individuals

发表于 2020-02-05 07:03   837次浏览

公告 [Amend] Statement of acquisition of beneficial ownership by individuals

发表于 2020-01-30 00:15   965次浏览

公告 [Amend] Statement of acquisition of beneficial ownership by individuals

发表于 2020-01-28 00:16   968次浏览

公告 Monthly Portfolio Investments Report on Form N-PORT (Public)

发表于 2019-11-26 11:25   926次浏览

公告 Fidelity Bond [Rule 17G-1(g)]

发表于 2019-11-23 01:08   960次浏览

公告 Certified Shareholder Report, Semi-Annual

发表于 2019-09-05 03:12   1082次浏览

公告 Annual Report of proxy voting record of management investment companies

发表于 2019-08-28 21:08   912次浏览

公告 Portfolio Holdings Exhibit to Form N-PORT

发表于 2019-05-30 18:47   1135次浏览

公告 Other definitive proxy statements

发表于 2019-05-09 20:16   982次浏览

公告 Annual Report for Registered Investment Companies

发表于 2019-03-19 00:33   967次浏览

公告 Certified Shareholder Report

发表于 2019-03-09 00:27   874次浏览

公告 [Amend] Statement of acquisition of beneficial ownership by individuals

发表于 2019-02-14 22:50   846次浏览

公告 [Amend] Statement of acquisition of beneficial ownership by individuals

发表于 2019-01-24 23:16   868次浏览

公告 [Amend] Statement of acquisition of beneficial ownership by individuals

发表于 2019-01-23 00:58   833次浏览

公告 [Amend] Statement of acquisition of beneficial ownership by individuals

发表于 2019-01-19 00:20   904次浏览